Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/hiv.12829
PubMed Identifier: 31927793
Publication URI: http://europepmc.org/abstract/MED/31927793
Type: Journal Article/Review
Volume: 21
Parent Publication: HIV medicine
Issue: 5
ISSN: 1464-2662